PARP1 and lung carcinoma: Despite the remarkable anticancer activity of CK against lung cancer cells, the molecular mechanisms underlying it require further investigation, and in this study, we identified a novel molecular mechanism induced by CK: caspase-independent PARP-1-mediated parthanatos and the role of SIRT6 in this process (Figure 7).